Blood Gas And Electrolyte Analyzers Market Expected To Witness A Substantial Growth Of USD 653.5 Million By 2022 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Blood Gas and Electrolyte Analyzers Market Size & Trends Analysis Report, By Product (Benchtop Blood Gas & Electrolyte Analyzers, Portable Blood Gas & Electrolyte Analyzers), By End-use, And Segment Forecasts, 2012 – 2022

Global blood gas and electrolyte market is expected to reach USD 653.5 million by 2022, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Access Research Report of Blood Gas and Electrolyte Analyzers Market @  www.grandviewresearch.com/industry-analysis/blood-gas-and-electrolyte-analyzers

Further key findings from the study suggest:

• Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.
• Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.
• North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
• Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.
• Key players of the blood gas and electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the blood gas and electrolyte analyzers market on the basis of products, application, end-use, and region:

Global Blood Gas and Electrolyte Analyzers Market, Product Outlook (Revenue, USD Million, 2012 – 2022)

• Benchtop
• Portable

Global Blood Gas and Electrolyte Analyzers Market, Application Outlook (Revenue, USD Million, 2012 – 2022)

• Blood gas analyzers
• Electrolyte analyzers
• Combined analyzers

Global Blood Gas and Electrolyte Analyzers Market, End-use Outlook (Revenue, USD Million, 2012 – 2022)

• Clinical laboratories
• Point-of-care

Blood Gas and Electrolyte Analyzers Market, Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Access Press Release of Blood Gas and Electrolyte Analyzers Market @ www.grandviewresearch.com/press-release/global-blood-gas-and-electrolyte-analyzers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Urinalysis Market Share And Trends To Reach Industry Size With USD 2.14 Billion By 2022 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Urinalysis Market Analysis By Product (Instruments, Consumables), By Application (Urinary Tract Infection, Diabetes, Kidney Diseases, Hypertension, Liver Diseases), By End-use (Hospitals, Clinical Laboratories, Home Healthcare, Research, and Academics) And Segment Forecasts To 2022

Global urinalysis market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.

Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.

The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.

The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.

Access Research Report of Urinalysis Market @ www.grandviewresearch.com/industry-analysis/urinalysis-market

Further key findings from the study suggest:

• Urinary Tract Infections (UTIs)dominated the application segment in 2014. The foremost factor responsible for its high share is the rising prevalence of UTIs, especially in females. However, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
• Consumables held the largest share with revenue generation of over USD 1 million in 2014. The increasing usage of test strips and reagents for urinalysisis one of the major factors that are attributed to its large market share. However, the instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment’s growth.
• The home healthcare segment, on the other hand, is anticipated to grow at a substantial rate over 7.5%. The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
• North America dominated the overall urinalysis market with a revenue generation of over USD 540 million in 2014. The introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending in this region are the key factors attributing to the largest market share of this region.
• Key players of this market include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex.
• Market participants are constantly engaged in the introduction of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, in June 2014, Roche launched a fully automated urine testing analyzer named Cobas 6500 with an objective to enhance staff safety and increase the result reliability.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global urinalysis market on the basis of product, application, end-use, and region:

Global Urinalysis Product Outlook (Revenue, USD Million, 2015 – 2022)

• Instruments
  • Biochemical urine analyzers
    • Automated biochemical analyzers
    • Semi-automated biochemical analyzers
  • Automated urine sediment analyzers
    • Microscopic urine analyzers
    • Flow-cytometric urine analyzers
  • Consumables
    • Dipsticks
    • Reagents
    • Disposables

Global Urinalysis Application Outlook (Revenue, USD Million, 2015 – 2022)

• UTIs
• Diabetes
• Kidney Disease
• Hypertension
• Liver disease
• Others

Global Urinalysis End-use Outlook (Revenue, USD Million, 2015 – 2022)

• Hospitals
• Clinical Laboratories
• Home healthcare
• Research and academics
• Others

Urinalysis Regional Outlook (Revenue, USD Million, 2015 – 2022)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Urinalysis Market @ www.grandviewresearch.com/press-release/global-urinalysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

X-ray Photoelectron Spectroscopy Market Progressing At USD 712.4 Million By 2022 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report X-ray Photoelectron Spectroscopy Market Size, Share & Trends Analysis Report By Usage (Element Detection) By Application (Healthcare) And Segment Forecasts, 2012 – 2022

The global XPS market is expected to reach USD 712.4 million by 2022, according to a new report by Grand View Research, Inc. Growing application of XPS technology in different industries such as healthcare, semiconductors, aerospace, automotive, and electronics along with rising demand for research and development across all these industries is expected to drive the XPS market over the forecast period.

In addition, rising popularity of hyphenated technologies and other technological advancements such as hard X-ray photoelectron spectroscopy (HAXPES) has prompted the growth of the X-ray photoelectron spectroscopy market. The ability of XPS to accurately identify contamination in the provided sample is also expected to contribute towards boosting usage rates.

Rising demand for XPS technique for drug safety and medical research is expected to serve the market as a future growth opportunity. Presence of supportive government initiatives such as the “Safe Use Initiative” by FDA and “Drug Safety Information Survey” introduced by Health Canada for creating awareness regarding medical research and development are some notable examples likely to provide manufacturers with lucrative growth opportunities.

Access Research Report of X-ray Photoelectron Spectroscopy Market @ www.grandviewresearch.com/industry-analysis/xps-market

Further key findings from the report suggest:

• The global element detection market is anticipated to reach 257.05 million by 2022, at a CAGR of 6.29% from 2015 to 2022
• In terms of usage, contamination detection segment is expected to show the fastest growth during the forecast period
• In terms of application, healthcare segment is expected to dominate the market over the forecast period
• Asia pacific is expected to show the fastest growth in XPS market over the forecast period
• North America is expected to dominate the XPS market during the forecast period
• The market is partially consolidated and competitive in nature, with presence of global multinational players.
• Some of the key companies present in the market include Thermo Fisher Scientific, Kratos Analytical, Evan Analytical Group (EAG), Intertek, V G Scienta, Yokogawa, Kett and Mitsubishi Electric.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global XPS market on the basis of usage, application and region:

X-ray Photoelectron Spectroscopy Usage Type Outlook (Revenue, USD Million, 2012 – 2022)

• Element Detection
• Contamination Detection
• Density Estimation
• Empirical formula Determination

X-ray Photoelectron Spectroscopy Application Type Outlook (Revenue, USD Million, 2012 – 2022)

• Healthcare
• Semiconductors
• Electronics
• Aerospace
• Automotive
• Others

X-ray Photoelectron Spectroscopy Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of X-ray Photoelectron Spectroscopy Market @ www.grandviewresearch.com/press-release/global-xps-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Cardiac Biomarkers Market To 2024 Forecasts By Type, Application, End Use, And Region : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Cardiac Biomarkers Market By Type (Troponin, Creatine kinase – MB (CK-MB), Natriuretic peptides – B-type Natriuretic Peptide (BNP) & N-terminal pro b-type Natriuretic peptide (NT-proBNP), Myoglobin, Ischemia Modified Albumin (IMA), Heart-type Fatty Acid Binding Protein (H-FABP), LDH isoenzymes), By Application (Acute Coronary Syndrome, Myocardial infarction, Congestive heart failure, Cardiomyopathy, Ischemia, Myocarditis, Atrial fibrillation), By End Use, By Region And Segment Forecasts To 2024

The cardiac biomarkers market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease diagnosis. Furthermore, this growth is attributed to a majority of factors, such as the high prevalence of Acute Coronary Syndrome (ACS), continual technological advancements in the development of cardiovascular biomarkers, increasing number of new product launches by the key market players, rising demand for point of care cardiac testing kits, along with the high specificity and sensitivity of these biomarkers in the detection of cardiovascular diseases, especially acute myocardial infarction.

The cardiac biomarkers market has been classified by type into troponin, Creatine kinase-MB(CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), myoglobin, and others. Troponin is a heteromeric protein and comprises cardiac troponin T & I, which are abbreviated as cTnT & cTnI, respectively. The troponin biomarkers segment is expected to grow lucratively in the forecast period at a significant CAGR. The diagnostic efficiency and specificity related to cardiac biomarker testing renders it a universally gold standard test to diagnose cardiovascular disorders worldwide. The market by application is segmented into acute coronary syndrome, myocardial infarction, congestive heart failure, and others. ACS is expected to be the highest grossing segment according to the study. ACS is responsible for huge medical costs globally and is responsible for most hospital readmission cases. The increasing efforts to cut down worldwide ACS prevalence rates are expected to drive the growth of the biomarkers market.

The key countries included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and the Middle East. North America accounted for the largest market in 2015, whereas the Asia Pacific region is anticipated to be the fastest growing region during the forecast period.

Access Research Report of Cardiac Biomarkers Market @ www.grandviewresearch.com/industry-analysis/cardiac-biomarker-market

Further key findings from the study suggest:

• North America is estimated to dominate the global cardiac biomarkers market. The high prevalence of coronary heart disease in western countries is one of the major factors contributing to the high demand for cardiac biomarker diagnostics.
• The Asia Pacific region is anticipated to be the fastest growing region in the study period owing to the large population, especially in China and India. Apart from that, there exists a high prevalence rate of myocardial infarction in the region. This prevalence rate is expected to fuel the demand for cardiac biomarker diagnostics.
• The troponin biomarker segment is expected to grow at a significant rate, and is expected to grow at the highest CAGR compared to others and accounts for the largest market share in 2015.
• The sector comprises of several local as well as global players. Some of the major players of this vertical include Alere, Inc., Siemens Healthcare GmbH, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and bioMerieux SA.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the cardiac biomarkers market on the basis of type, application, end use, and region:

Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 – 2024)

• Troponin
• CK-MB
• Natriuretic peptides – BNP and NT-proBNP
• Myoglobin
• Others

Cardiac Biomarkers Market Application Outlook (Revenue, USD Million, 2013 – 2024)

• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure
• Others

Cardiac Biomarkers Market End-use Outlook (Revenue, USD Million, 2013 – 2024)

• Laboratory Testing
• Point of Care Testing

Cardiac Biomarkers Regional Outlook (Revenue, USD Million, 2013 – 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Cardiac Biomarkers Market @ www.grandviewresearch.com/press-release/global-cardiac-biomarker-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

 

Medical Disposables Market Worth $ 329.9 Billion By 2024 : Grand View Research Inc.

San Francisco, 29 August 2019: The Report Medical Disposables Market Revenue Analysis by Product (Wound Management, Drug Delivery, Diagnostic and Laboratory, Dialysis, Incontinence, Respiratory Supplies, Sterilization, Nonwoven), by Raw Material (Plastic Resin, Nonwoven Material, Rubber, Paper and Paperboard, Metals, Glass), and by End Use (Hospitals, Home Healthcare, Outpatient/Primary Care Facilities) Segment Forecasts to 2024

The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure.

In addition, propelling factors of this sector comprise constantly rising hospital visits, surgeries, and the growing need for healthcare assistance owing to the escalating geriatric population prone to developing chronic diseases and injuries. Furthermore, the emergence of this sector is attributed to the increased focus toward the use of single-use disposable products to prevent cross-contamination and infection in healthcare settings.

These products offer a range of advantages to the healthcare institutions such as reducing sterilization and disinfection costs. Thus, most of the healthcare professionals and individual patients are turning toward disposable medical supplies to meet the infection control requirements.

Drug delivery products captured the largest revenue share in 2015. The segment is also expected to foresee the fastest growth rate due to the increasing use of prefilled syringes, needles, and transdermal patches by various hospitals and clinics.

The plastic resin segment accounted for the largest share in 2015 due to their wide availability and application in the healthcare sector. However, nonwoven material is forecasted to grow at the fastest CAGR owing to factors such as their low weight, affordable cost, and easy recycling methods. Nonwoven fabric is the material of choice for a number of applications such as wound care management, incontinence management, and surgeries due to the highly absorbent and liquid repellent nature of this material, among other properties.

Access Research Report of Medical Disposables Market @ www.grandviewresearch.com/industry-analysis/medical-disposables-market

Further Key Findings from the Study Suggest:

• In 2015, the drug delivery product segment captured the largest revenue share. The increasing application of various drug delivery products for sustained-release drug therapies is mainly contributing to the largest share of the segment globally.
• In addition, rising demand for minimally invasive surgeries is spurring the demand for needles and drug delivery devices, which is resulting in the high revenue generation of the segment
• With the introduction of advanced technology and growing demand for accurate diagnostic methods, the diagnostic and laboratory disposables segment is expected to show the second fastest growth during the forecast period
• North America region dominated the overall market by capturing over 35.0% share in 2015. This region is anticipated to remain dominant throughout the forecast period.
• Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, large patient pool, and the presence of a large number of major players in the region
• Growing economies and government-led initiatives are expected to drive the growth of the medical disposables sector in the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 7% during the forecast period.
• Some of the major players in the consolidated market are 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health

Access Research Insights of Medical Disposables Market @  www.grandviewresearch.com/research-insights/medical-disposables-effective-infection-control-measures

Grand View Research has segmented the medical disposables market by product, raw material, end use, and region:

Type Outlook (Market revenue in USD Million, 2014 – 2024)

• Wound Management Products
• Drug Delivery Products
• Diagnostic and Laboratory Disposables
• Dialysis Disposables
• Incontinence Products
• Respiratory Supplies
• Sterilization Supplies
• Nonwoven Disposables
• Others

Raw Material Outlook (Market revenue in USD Million, 2014 – 2024)

• Plastic Resins
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others

End Use Outlook (Market revenue in USD Million, 2014 – 2024)

• Hospitals
• Home Healthcare
• Outpatient/Primary care Facilities
• Others

Regional Outlook (Market Revenue in USD Million, 2014 – 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Access Press Release of Medical Disposables Market @ www.grandviewresearch.com/press-release/global-medical-disposables-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Pruritus Therapeutics Market Size ,Share ,Industry Growth ,Key Players And Forecast To 2025 : Grand View Research Inc.

San Francisco, 28 August 2019: The Report Pruritus Therapeutics Market By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Pipeline, Unmet Needs), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria) Analysis And Segment Forecasts To 2025

Global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period. Introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period.

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

Access Research Report of Pruritus Therapeutics Market @ www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market

Further key findings from the study suggest:

• Calcineurin inhibitor is identified as the most lucrative segment of the market on account of high usage rate of these drugs in combination therapy for the treatment of pruritus in patients suffering from chronic pruritus and growing market penetration rates. Moreover, the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive this market.
• Anti-histamines owing to its growing use as a first line treatment and presence of drugs in pipeline with expected commercialization is also expected to grow at a healthy rate during the forecast period.
• North America led the overall market in terms of revenue in 2013 majorly on account of the presence of high prevalence of diseases associated with pruritus, introduction of new products targeting the unmet medical needs and growing patient awareness levels.
• The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over 5.0% during the forecast period. Presence of high unmet healthcare needs and increasing prevalence of allergic contact dermatitis and urticaria in this region are some factors attributing to its rapid growth rate.
• Some key participants of the pruritus therapeutics market include Sanofi, Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
• Manufacturers adhere to rigorous R&D in an attempt to develop cost effective products and avoid barriers such as product recalls. In addition, this strategy is implemented keeping the unmet needs in consideration. For Instance, Creabilis has a molecule in the pipeline – CT327, which caters to the unmet needs associated with pruritus in patients suffering from psoriasis.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global pruritus therapeutics market on the basis of product, disease type and region:

Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 – 2025)

• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others

Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 – 2025)

• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

Global Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 – 2025)

• North America
• Europe
• Asia Pacific
• RoW

Access Press Release of Pruritus Therapeutics Market @ www.grandviewresearch.com/press-release/global-pruritus-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Smart Pills Market Poised To Augment The Industry At $3.0 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 August 2019: The Report Smart Pills Market Analysis By Application (Products [Capsule Endoscopy, Drug Delivery], Tools, and Patient Monitoring Software), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), And Segment Forecasts, 2018 – 2025

The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. Increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive market growth over the forecast period.

Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum. Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.

Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis. Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients.

Established players in this market are enhancing their portfolio by upgrading existing devices. On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.

Access Research Report of Smart Pills Market @ www.grandviewresearch.com/industry-analysis/smart-pills-market

Further key findings from the report suggest:

• Capsule endoscopy is the largest application segment owing to factors such as growth in cancer screening awareness programs, increase in incidence of Crohn’s disease and bowel cancer, and increase in demand for minimally invasive procedures
• North America is the dominant region with the largest revenue share. Wide availability of products, favorable reimbursement policies, increase in government investments in healthcare, and an overall rise in healthcare expenditure support market growth
• Asia Pacific is expected to witness the fastest growth over the forecast period. Factors such as increase in disposable income, mandatory healthcare insurance, and rise in healthcare expenditure are expected to drive the market
• Commercially available smart pills include PillCam Capsule, ABILIFY MYCITE, CapsoCam, and Olympus Endocapsule
• Key players in the smart pills market include Medtronic, Olympus Corporation, Proteus digital Health, MediSafe, and CapsoVision

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the smart pills market on the basis of application and region:

Application Outlook (Revenue, USD Million, 2014 – 2025)

• Product
  • Capsule Endoscopy
  • Drug Delivery
• Tools
• Patient Monitoring Software

Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Smart Pills Market @ www.grandviewresearch.com/press-release/global-smart-pills-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hormone Replacement Therapy (HRT) Market Business Plans, Innovative Technology, and Growth Factors And Forecast To 2022 : Grand View Research Inc.

San Francisco, 28 August 2019: The Report Hormone Replacement Therapy (HRT) Market  By Product (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Route of Administration (Oral, Parenteral, Transdermal), By Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency) And Segment Forecasts to 2022

Global hormone replacement therapy market is expected to reach USD 28.4 billion by 2022, according to a new report by Grand View Research, Inc. Increasing geriatric and neonatal population base, growing cases of hormonal imbalances, and large presence of unmet healthcare needs in emerging economies are some vital impact rendering drivers.

Estrogen replacement therapy dominated the market in 2015. Moreover, the rising number of women reaching the menopausal age is expected to drive the demand for these treatments over the forecast period.

Furthermore, rise in premature births that lead to genital disorders and slower rate of growth in these neonates are anticipated to fuel the demand for growth hormone therapy. According to statistics provided by the CDC, over 15 million babies were born preterm in 2014 annually. This number is anticipated to rise over the next seven years and become a leading cause for disabilities, illnesses, arrested development, and mortality.

Access Research Report of Hormone Replacement Therapy (HRT) Market @ www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market

Further key findings from the study suggest:

• Estrogen therapy is expected to dominate the product segment and hold over 50.0% of the market share by 2022. This growth can be attributed to the increasing focus of healthcare bodies such as the Women’s Health Initiative, The North America Menopause Society, and The British Menopause Society, on providing safe replacement therapy.
• The parenteral route of administration is commonly used for delivery of drugs such as Nutropin, Signifor, Genotropin, and Tev-Tropin. Other routes such as pen-based delivery systems and implants are gaining popularity owing to higher patient comfort and ease-of-use. Furthermore, technological advancements in the field providing higher bioavailability of drug and needle-free administration are predicted to positively impact growth.
• Menopause and their vasomotor symptoms are expected to be the most prevalent disease over the forecast period owing to increasing number of women approaching the menopausal age. The segment is predicted to hold about 40.0% of the market share by 2022.
• North America, particularly the U.S. dominated the market and held about 35.0% of the total revenue in 2015. Existence of well-regulated healthcare system and presence of a large pool of target population are a few factors that promote growth. Countries such as South Africa, China, India, and Brazil are anticipated to witness lucrative growth over the forecast period, with China predicted to have the fastest growth of over 10.0%.
• Some key companies catering to hormone replacement therapies include Pfizer, Inc., Merck Serono, Novo Nordisk, Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and Genentech. Introduction of new formulations and development of innovative drug delivery systems are expected to be a few initiatives taken by these players over the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the hormone replacement therapy market on the basis of product, route of administration, disease type, and region

Hormone Replacement Therapy Market Product Outlook (Revenue, USD Million, 2012 – 2022)

• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Other

Hormone Replacement Therapy Market Route Of Administration Outlook (Revenue, USD Million, 2012 – 2022)

• Oral
• Parenteral
• Transdermal
• Other

Hormone Replacement Therapy Market Type Of Disease Outlook (Revenue, USD Million, 2012 – 2022)

• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Other

Hormone Replacement Therapy Market Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Hormone Replacement Therapy (HRT) Market @ www.grandviewresearch.com/press-release/global-hormone-replacement-therapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Pediatric Vaccines Market Value To Reach USD 60.4 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 August 2019: The Report Pediatric Vaccines Market Analysis By Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate), By Application (Infectious Diseases, Cancer, Allergy), By Region, And Segment Forecasts, 2018 – 2025

The global pediatric vaccines market is expected to reach USD 60.4 billion by 2025 at an 11.7% CAGR, according to a new report by Grand View Research, Inc. Advancements in development of vaccines and new product launches are some of the major drivers of the market.

Increase in investments by companies to capture a larger market share is anticipated to propel growth. Some of the factors attributed to increase in investment are high growth prospects in the emerging market, immunization schedule mandated by doctors for children, and awareness programs led by UNICEF, WHO, and other healthcare organizations. Furthermore, increase in number of government initiatives for raising awareness about immunization is expected to boost the market for pediatric vaccines.

Advancements in development of novel adjuvants and therapeutic vaccines are expected to drive growth during the forecast period. Ongoing research in novel molecules targeted at specific mechanisms of action in the body is aimed at providing immunity against fatal diseases such as cancer and Zika virus disease. For instance, in June 2016, Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial for their Zika DNA vaccine named GLS-5700.

Access Research Report of Pediatric Vaccines Market @ www.grandviewresearch.com/industry-analysis/pediatric-vaccine-market

Further key findings from the report suggest:

• The global pediatric vaccines market was estimated at USD 22.4 billion in 2016 and is expected to grow with a CAGR of 11.7% from 2017 to 2025
• By type, monovalent emerged as the largest segment due to factors such as high usage and increase in initiatives for R&D activities supported by various governments
• Conjugate vaccines formed the dominant technology segment in terms of revenue in 2016. Higher adoption of these vaccines and increase in prevalence of infectious diseases contribute to its lead in the market for pediatric vaccines
• By application, the cancer segment is expected to witness the fastest growth with a CAGR of 12.6% owing to increasing prevalence of cancer and rising need for immunization against the disease
• North America held the largest revenue share in 2016. Its dominance in the market for pediatric vaccines is owing to factors such as local presence of major players in the industry and extensive R&D activities
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increase in prevalence of infectious diseases and a large target population
• Key players such as GlaxoSmithKline plc; Pfizer, Inc.; SANOFI; and AstraZeneca dominated the global market for pediatric vaccines in 2016.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global pediatric vaccines market on the basis of type, technology, application, and region:

Type Outlook (Market Revenue in USD Billion, 2014 – 2025)

• Monovalent
• Multivalent

Technology Outlook (Market Revenue in USD Billion, 2014 – 2025)

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Application Outlook (Market Revenue in USD Billion, 2014 – 2025)

• Infectious disease
• Cancer
• Allergy

Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Pediatric Vaccines Market @ www.grandviewresearch.com/press-release/global-pediatric-vaccine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Orthobiologics Market Size Was Valued At USD 10.2 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 August 2019: The Report Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment Forecasts, 2018 – 2025

The global orthobiologics market size is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics industry trends is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period and will help grow the competition among the key players, particularly in U.S. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.

These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics device market during the forecast period.

Access Research Report of Orthobiologics Market @ www.grandviewresearch.com/industry-analysis/orthobiological-products-market

Further Key Findings From the Study Suggest:

• In 2015, viscosupplementation accounted for the largest share in the product segment owing to being a cost efficient therapeutic alternative for symptomatic management of osteoarthritis
• Spinal fusion held the largest share in the application segment in 2015, owing to presence of third party insurers and reimbursement structure for fusion enhancement products thus triggering growth
• In 2015, North America accounted for the dominant share owing to consistent efforts of industry players in promoting awareness pertinent to the orthobiological products resulting in significant rise in adoption rate
• Asia Pacific is anticipated to exhibit an exponential CAGR as a consequence of significant surge in healthcare spending and awareness levels with respect to the availability of orthobiologics
• The prominent players are consistently indulging into extensive strategies to gain competitive position including regional expansion and mergers & acquisitions to capture a greater share of the orthobiologics market
• For instance, in November 2015, Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This acquisition was carried out to expand orthobiologics product portfolio and grafting solutions in order to expand their market share

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the orthobiologics market on the basis of product, application, end use, and region:

Orthobiologics Product Outlook (Revenue, USD Billion, 2014 – 2025)

• Demineralized Bone Matrix(DBM)
• Allograft
• Bone Morphogenetic Protein (BMP)
• Viscosupplementation
• Synthetic Bone Substitutes
• Stem Cell Therapy

Orthobiologics Application Outlook (Revenue, USD Billion, 2014 – 2025)

• Spinal Fusion
• Trauma Repair
• Reconstructive Surgery

Orthobiologics End-use Outlook (Revenue, USD Billion, 2014 – 2025)

• Hospitals
• Orthopedic Clinics

Orthobiologics Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Access Press Release of Orthobiologics Market @ www.grandviewresearch.com/press-release/global-orthobiological-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com